Shanghai
China
344
2026-09-24
The entities that hold a legal rights for patent applications filed by inventor CHEN Shuhui:
Shuhui CHEN from Shanghai, CN has applied for patents for these inventions. The list has both pending applications and granted patents:
FUSED RING DERIVATIVES CONTAINING 1,4-OXAZEPANE
#2 | 2026-09-17DEUTERIUM-SUBSTITUTED PYRIDAZINE BENZOTHIOPHENE COMPOUND AND USE THEREOF
#3 | 2026-09-03HETEROCYCLIC SUBSTITUTED PYRIMIDOPYRAN COMPOUND AND USE THEREOF
#4 | 2026-07-16FUSED TRICYCLIC DERIVATIVE AND PHARMACEUTICAL APPLICATION THEREOF
#5 | 2026-03-26STAPLED PEPTIDE AND USE THEREOF
#6 | 2026-03-12CONJUGATE OF NUCLEOTIDE ANALOG-CONTAINING DOUBLE-STRANDED RNAI ANALOG
#7 | 2026-02-26SERIES OF NITROGEN-CONTAINING BRIDGED HETEROCYCLIC COMPOUNDS AND PREPARATION METHOD THEREFOR
#8 | 2026-01-15PIPERAZINE BRIDGE-SUBSTITUTED HETEROCYCLIC PYRIMIDINE COMPOUND
#9 | 2025-10-23STAPLE-CONTAINING POLYPEPTIDES AND APPLICATION THEREOF
#10 | 2025-09-25FLUOROQUINOXALINONE DERIVATIVE FOR SELECTIVELY INHIBITING PARP1
#11 | 2025-09-11HETEROARYL-SUBSTITUTED BICYCLIC COMPOUND AND USE THEREOF
#12 | 2025-08-28BENZOPYRIMIDINE COMPOUNDS AND USE THEREOF
#13 | 2025-08-28MACROCYCLIC DERIVATIVE AND USE THEREOF
#14 | 2025-08-28CRYSTAL FORM OF AZETIDINE-SUBSTITUTED COMPOUND
#15 | 2025-08-07HETEROCYCLIC SUBSTITUTED PYRIMIDOPYRAN COMPOUND AND USE THEREOF
#16 | 2025-08-07ANTI-INFLUENZA VIRUS PYRIMIDINE DERIVATIVES
#17 | 2025-06-26MACROCYCLIC DERIVATIVE AND USE THEREOF
#18 | 2025-05-22PYRIDONE OR PYRIMIDONE DERIVATIVE AND APPLICATION THEREOF
#19 | 2025-05-15HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR
#20 | 2025-05-15PYRIMIDOHETEROCYCLIC COMPOUNDS AND APPLICATION THEREOF
#21 | 2025-05-15COUMARIN COMPOUNDS AND USES THEREOF
#22 | 2025-04-24CRYSTAL FORM OF PYRIMIDINE HETEROCYCLIC COMPOUND AND PREPARATION METHOD THEREFOR
#23 | 2025-04-24GLUTARIMIDE COMPOUND AND USE THEREOF
#24 | 2025-04-17HALOGEN-SUBSTITUTED PYRIDAZINONE COMPOUND AND APPLICATION THEREOF
#25 | 2025-04-17POLYPEPTIDE DRUG CONJUGATE HAVING NOVEL STRUCTURE AND APPLICATION THEREOF
#26 | 2025-04-03BRIDGED RING-SUBSTITUTED HETEROARYL-PYRAN DERIVATIVE, AND USE THEREOF
#27 | 2025-03-13MACROCYCLIC AMIDE COMPOUNDS AND APPLICATION THEREOF
#28 | 2025-03-13SALT FORM AND CRYSTAL FORM OF TETRAHYDROCYCLOHEPTA INDAZOLE COMPOUND
#29 | 2025-02-27PYRIMIDOPYRAN COMPOUND
#30 | 2025-02-20PYRAZOLE-1(2H)-PHTHALAZINONE COMPOUND AND APPLICATION THEREOF
#31 | 2025-02-06NOVEL NON-FLUORINATED QUINOLONE COMPOUND AND USE THEREOF
#32 | 2025-01-30BENZOXAZINONE DERIVATIVES
#33 | 2025-01-09PYRAZOLO FUSED RING COMPOUND AND USE THEREOF
#34 | 2024-12-26TRICYCLIC POLYPEPTIDE CONJUGATED DRUG AND USE THEREOF
#35 | 2024-12-12PYRIMIDINE TRICYCLIC DERIVATIVE AND PHARMACEUTICAL APPLICATION THEREOF
#36 | 2024-12-12CRYSTAL FORM OF METHYLPYRAZOLE-SUBSTITUTED PYRIDOIMIDAZOLE COMPOUND AND PREPARATION METHOD THEREFOR
#37 | 2024-12-052,6-PIPERIDINEDIONE COMPOUND AND APPLICATION THEREOF
#38 | 2024-11-28RING-MODIFIED PROLINE SHORT PEPTIDE COMPOUND AND USE THEREOF
#39 | 2024-11-28TRICYCLIC COMPOUNDS AND USE THEREOF
#40 | 2024-11-21BENZOPYRIMIDINE COMPOUNDS AND USE THEREOF
#41 | 2024-11-215-SUBSTITUTED PYRIDINE-2(1H)-KETONE COMPOUND AND USE THEREOF
#42 | 2024-11-07IMIDAZOCYCLIC COMPOUND AND APPLICATION THEREOF
#43 | 2024-10-31Heterocycloalkyl compounds as CCR2 / CCR5 antagonists
#44 | 2024-10-10SULFUR/PHOSPHORUS-CONTAINING ARYL COMPOUND AND APPLICATION THEREOF
#45 | 2024-10-03DEUTERATED NUCLEOSIDE COMPOUNDS AND USE THEREOF
#46 | 2024-10-03PYRIMIDOPYRAN COMPOUND
#47 | 2024-09-26HETEROARYL-3-PIPERIDINEDIONE COMPOUND AND USE THEREOF
#48 | 2024-09-26ALKYL CARBOXYLIC ACID COMPOUNDS AND APPLICATION THEREOF
#49 | 2024-09-19THIAZOLE-LACTAM-SPIROHETEROCYCLIC COMPOUNDS AND APPLICATIONS THEREOF
#50 | 2024-09-12DIMETHYL-SUBSTITUTED THIAZOLOLACTAM COMPOUND AND USE THEREOF
#51 | 2024-09-12TETRAHYDROPYRROLOCYCLIC COMPOUND AND APPLICATION THEREOF
#52 | 2024-09-05FUSED TRI-CYCLIC COMPOUND AS A PDE3/PDE4 DUAL INHIBITOR
#53 | 2024-08-29DEUTERATED NUCLEOSIDE COMPOUNDS AND USE THEREOF
#54 | 2024-08-22SALT FORM AND CRYSTAL FORM THEREOF OF SULFONYLUREA RING SUBSTITUTED COMPOUND
#55 | 2024-08-15PREPARATION AND APPLICATION OF POLYPEPTIDE
#56 | 2024-08-08DEUTERATED NUCLEOSIDE COMPOUNDS AND USE THEREOF
#57 | 2024-08-01SALT FORM AND CRYSTAL FORM OF HETEROCYCLIC SUBSTITUTED PURINONE DERIVATIVE
#58 | 2024-08-01SALT FORM OF PYRROLOTRIAZINE COMPOUND, CRYSTAL FORM THEREOF, AND PREPARATION METHOD THEREFOR
#59 | 2024-07-18BICYCLIC PHENOL COMPOUNDS AND USE THEREOF
#60 | 2024-07-18PIPERAZINE DERIVATIVES AND APPLICATION THEREOF
#61 | 2024-07-04IMIDAZOPYRIDINE COMPOUNDS AND USE THEREOF
#62 | 2024-07-04BICYCLIC SUBSTITUTED AROMATIC CARBOXYLIC ACID COMPOUNDS
#63 | 2024-07-04COMPOUND FOR USE IN RETINAL DISEASES
#64 | 2024-06-276-CARBAMATE SUBSTITUTED HETEROARYL RING DERIVATIVES
#65 | 2024-06-20THIOPHENE COMPOUND AND APPLICATION THEREOF
#66 | 2024-06-13AMINOPYRIMIDINE COMPOUND AS CDK2/4/6 TRIPLE INHIBITOR
#67 | 2024-06-13FURAN FUSED RING-SUBSTITUTED GLUTARIMIDE COMPOUND
#68 | 2024-06-13SUBSTITUTED PYRIDINE-2,4-DIONE DERIVATIVES
#69 | 2024-06-06OXADIAZOLE-SUBSTITUTED SPIROCYCLIC COMPOUND AND APPLICATION THEREOF
#70 | 2024-05-30PYRIMIDINE AROMATIC RING COMPOUNDS
#71 | 2024-05-23SUBSTITUTED PYRIDAZINE PHENOL DERIVATIVES
#72 | 2024-05-16FUSED POLYCYCLIC SUBSTITUTED 5-CARBOXYLIC ACID THIENOPYRIMIDINE DIONE COMPOUND AND USE THEREOF
#73 | 2024-05-16RING-MODIFIED PROLINE SHORT PEPTIDE COMPOUND AND USE THEREOF
#74 | 2024-05-09FUSED RING DERIVATIVES CONTAINING 1,4-OXAZEPANE
#75 | 2024-05-025,6-DIHYDROTHIENO[3,4-H]QUINAZOLINE COMPOUND
#76 | 2024-04-25SALT FORM AND CRYSTAL FORM OF PYRAZOLE SUBSTITUTED IMIDAZO[1,2- A]QUINOXALINE DERIVATIVE
#77 | 2024-04-25INDOLINE COMPOUND
#78 | 2024-04-25BENZO SEVEN-MEMBERED RING BIFUNCTIONAL COMPOUND AND APPLICATION THEREOF
#79 | 2024-04-11Pyrimidoheterocyclic compounds and application thereof
#80 | 2024-04-04BENZIMIDAZOLE COMPOUND AND APPLICATION THEREOF
#81 | 2024-04-04SERIES OF PIPERIDINE-SUBSTITUTED BENZOIC ACID COMPOUNDS, AND USE THEREOF
#82 | 2024-02-29LACTAM-MODIFIED POLYPEPTIDE COMPOUNDS
#83 | 2024-02-08CLASS OF 1,7-NAPHTHYRIDINE COMPOUNDS AND APPLICATION THEREOF
#84 | 2024-02-08SALT FORM OF TETRA-SUBSTITUTED OLEFIN COMPOUND, CRYSTAL, AND PREPARATION METHOD THEREFOR
#85 | 2024-02-01CONJUGATE GROUP AND CONJUGATE
#86 | 2024-01-25PYRIDONE MULTIPLE-MEMBERED RING DERIVATIVES AND USE THEREOF
#87 | 2024-01-25SALT FORM USED AS CDC7 INHIBITOR AND CRYSTAL FORM THEREOF
#88 | 2024-01-04PYRROLOPYRIDINE COMPOUND AND APPLICATION THEREOF
#89 | 2023-12-28AMINOPYRIDINE COMPOUND AND APPLICATION THEREOF
#90 | 2023-12-07AMIDE OXAZOLE COMPOUND
#91 | 2023-11-16CRYSTAL FORMS OF PYRIDOPYRAZOLE COMPOUNDS AND PREPARATION METHOD THEREFOR
#92 | 2023-11-16TETRAHYDROISOQUINOLINE DERIVATIVE AND USE THEREOF
#93 | 2023-11-16CRYSTAL FORM OF PYRIDINYLPHENYL COMPOUND AND PREPARATION METHOD THEREFOR
#94 | 2023-11-09OCTAHYDROPYRAZINODIAZANAPHTHYRIDINE DIONE COMPOUNDS
#95 | 2023-11-09PYRROLOPYRIMIDINE COMPOUND AS BTK INHIBITOR AND USE THEREOF
#96 | 2023-11-091H-PYRROLO[2,3-C]PYRIDINE COMPOUNDS AND APPLICATION THEREOF
#97 | 2023-11-02ISOCHROMAN COMPOUND
#98 | 2023-11-02Bicyclic compound that acts as CRBN protein regulator
#99 | 2023-10-26Anti-influenza virus pyrimidine derivatives
#100 | 2023-10-19INDOLO HEPTAMYL OXIME ANALOG CRYSTAL AS PARP INHIBITOR AND METHOD FOR PREPARING SAME
1212224 ⎘